# Phyllis I. Spuls

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/phyllis-i-spuls/

## Facts

| Field | Value |
| --- | --- |
| Citations | 16,880 |
| Field | Dermatology and Skin Diseases |
| h-index | 63 |
| i10-index | 205 |
| Last Known Institution | Amsterdam Neuroscience |
| OpenAlex ID | https://openalex.org/A5072786878 |
| ORCID iD | https://orcid.org/0000-0002-6035-2863 |
| Works | 395 |

## Researcher papers

- [EASI, (objective) SCORAD and POEM for atopic eczema: responsiveness and minimal clinically important difference](https://scholariq.org/papers/easi-objective-scorad-and-poem-for-atopic-eczema-responsiveness-and-minimal/)
- [Increasing Comorbidities Suggest that Atopic Dermatitis Is a Systemic Disorder](https://scholariq.org/papers/increasing-comorbidities-suggest-that-atopic-dermatitis-is-a-systemic-disorder/)
- [Efficacy and safety of systemic treatments for moderate-to-severe atopic dermatitis: A systematic review](https://scholariq.org/papers/efficacy-and-safety-of-systemic-treatments-for-moderate-to-severe-atopic/)
- [The Harmonising Outcome Measures for Eczema (HOME) statement to assess clinical signs of atopic eczema in trials](https://scholariq.org/papers/the-harmonising-outcome-measures-for-eczema-home-statement-to-assess-clinical/)
- [Assessment of clinical signs of atopic dermatitis: A systematic review and recommendation](https://scholariq.org/papers/assessment-of-clinical-signs-of-atopic-dermatitis-a-systematic-review-and/)
- [When does atopic dermatitis warrant systemic therapy? Recommendations from an expert panel of the International Eczema Council](https://scholariq.org/papers/when-does-atopic-dermatitis-warrant-systemic-therapy-recommendations-from-an/)
- [The Harmonizing Outcome Measures for Eczema (HOME) Roadmap: A Methodological Framework to Develop Core Sets of Outcome Measurements in Dermatology](https://scholariq.org/papers/the-harmonizing-outcome-measures-for-eczema-home-roadmap-a-methodological/)
- [The role of bacterial skin infections in atopic dermatitis: expert statement and review from the International Eczema Council Skin Infection Group](https://scholariq.org/papers/the-role-of-bacterial-skin-infections-in-atopic-dermatitis-expert-statement-and/)
- [Towards global consensus on outcome measures for atopic eczema research: results of the <scp>HOME II</scp> meeting](https://scholariq.org/papers/towards-global-consensus-on-outcome-measures-for-atopic-eczema-research-results/)
- [Patient-Oriented Eczema Measure (POEM), a core instrument to measure symptoms in clinical trials: a Harmonising Outcome Measures for Eczema (HOME) statement](https://scholariq.org/papers/patient-oriented-eczema-measure-poem-a-core-instrument-to-measure-symptoms-in/)
- [Report from the fifth international consensus meeting to harmonize core outcome measures for atopic eczema/dermatitis clinical trials (HOME initiative)](https://scholariq.org/papers/report-from-the-fifth-international-consensus-meeting-to-harmonize-core-outcome/)
- [Factors associated with adverse COVID-19 outcomes in patients with psoriasis—insights from a global registry–based study](https://scholariq.org/papers/factors-associated-with-adverse-covid-19-outcomes-in-patients-with-psoriasis/)

## Researcher topics

- [Dermatology and Skin Diseases](https://scholariq.org/topics/dermatology-and-skin-diseases/)
- [Psoriasis: Treatment and Pathogenesis](https://scholariq.org/topics/psoriasis-treatment-and-pathogenesis/)
- [Allergic Rhinitis and Sensitization](https://scholariq.org/topics/allergic-rhinitis-and-sensitization/)
- [Asthma and respiratory diseases](https://scholariq.org/topics/asthma-and-respiratory-diseases/)
- [Delphi Technique in Research](https://scholariq.org/topics/delphi-technique-in-research/)

## Researcher university

- [Amsterdam Neuroscience](https://scholariq.org/institutions/amsterdam-neuroscience/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.
